Industry news, page-365

While on the subject of anxiety, this is a disturbing report re the effect of the pandemic. The IHL Psylocybin study on GAD (General Anxiety Disorder) very relevant. IMO there may be a link between continued exposure to stress (eg continued emotional fear mongering by the media, constant reminders like wearing masks, sanitising, QR code check in, new strains, lockdowns, job security etc... etc...) and the risk of people developing a chronic "anxiety" state.

IHL is unique given that 675A and Psylocybin potentially treat both the physical and mental consequences of Covid. (as well as a range of other disease states) IMO "treatment" will be the emerging paradigm as we see new strains and the avoidance of lockdowns.